Principal Short-Term Income Fund R-5 Class
PSIQX
NASDAQ
Weiss Ratings | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C- | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Company Info | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Principal Funds | |||
Manager/Tenure (Years) | Scott J. Peterson (15), Michael Goosay (1), Jeff Callahan (0) | |||
Website | -- | |||
Fund Information | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Principal Short-Term Income Fund R-5 Class | |||
Category | Short-Term Bond | |||
Sub-Category | US Fixed Income | |||
Prospectus Objective | Corporate Bond - High Quality | |||
Inception Date | Jul 12, 2010 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 0.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 3.58% | |||
Dividend | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | -- | |||
Asset Allocation | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 0.66% | |||
Stock | 0.00% | |||
U.S. Stock | 0.00% | |||
Non-U.S. Stock | 0.00% | |||
Bond | 99.34% | |||
U.S. Bond | 86.42% | |||
Non-U.S. Bond | 12.92% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.01% | |||
30-Day Total Return | 0.24% | |||
60-Day Total Return | 0.46% | |||
90-Day Total Return | 1.33% | |||
Year to Date Total Return | 1.82% | |||
1-Year Total Return | 5.67% | |||
2-Year Total Return | 10.11% | |||
3-Year Total Return | 12.24% | |||
5-Year Total Return | 10.05% | |||
Price | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $12.06 | |||
1-Month Low NAV | $11.98 | |||
1-Month High NAV | $12.10 | |||
52-Week Low NAV | $11.81 | |||
52-Week Low NAV (Date) | May 29, 2024 | |||
52-Week High NAV | $12.12 | |||
52-Week High Price (Date) | Sep 27, 2024 | |||
Beta / Standard Deviation | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.98 | |||
Standard Deviation | 2.33 | |||
Balance Sheet | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 3.29B | |||
Operating Ratios | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.62% | |||
Turnover Ratio | 46.70% | |||
Performance | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 4.22% | |||
Last Bear Market Total Return | -1.46% | |||